Simcere Pharmaceutical Group Limited (HKG:2096)
Hong Kong
· Delayed Price · Currency is HKD 12.40
+0.38 (3.16%)
At close: Feb 27, 2026
HKG:2096 Revenue
Simcere Pharmaceutical Group had revenue of 3.58B CNY in the half year ending June 30, 2025, with 6.01% growth. This brings the company's revenue in the last twelve months to 7.11B, up 12.10% year-over-year. In the year 2024, Simcere Pharmaceutical Group had annual revenue of 6.64B with 0.41% growth.
Revenue (ttm)
7.11B CNY
Revenue Growth
+12.10%
P/S Ratio
4.12
Revenue / Employee
1.04M CNY
Employees
6,815
Market Cap
32.05B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.64B | 27.41M | 0.41% |
| Dec 31, 2023 | 6.61B | 283.72M | 4.49% |
| Dec 31, 2022 | 6.32B | 1.32B | 26.49% |
| Dec 31, 2021 | 5.00B | 491.00M | 10.89% |
| Dec 31, 2020 | 4.51B | -527.94M | -10.48% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2012 | Pro | Pro | Pro |
| Dec 31, 2011 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| OneRobotics (Shenzhen) | 801.23M |
| China Resources Pharmaceutical Group | 285.94B |
| Xuanzhu Biopharmaceutical | 35.02M |
| Grand Pharmaceutical Group | 11.70B |
| China Medical System Holdings | 8.61B |
| The United Laboratories International Holdings | 15.45B |
| Sunshine Lake Pharma | 3.96B |
| Ab&B Bio-Tech CO., LTD. JS | 354.77M |